aktiencheck.de - Forum - Manhattan Pharamceuticals

Ein Blick sollte sich lohnen

Wert bewegt, sich momentan ständig zwischen 0,0185 und 0,0240 .Mit einem engen Stopp bei 0,0165 kann man hier nicht viel falsch machen, der Rest ist nur eine Frage der Zeit.Allen investierten viel Erfolg. [mehr]

MHAN kurz vor der Zulassung von Hedrin?

Hedrin and Management Restructuring, Manhattan Pharmaceuticals Provides Corporate Update on Hedrin and Management Restructuring "...The Company also announced it has initiated a management restructuring that is intended to extend the Company's resources and allow it to continue working toward its near-term corporate objectives and to maximize the value of its assets." http://ir.manhattanpharma.com//ReleaseDetail. [mehr]

MANHATTAN PHAR.NEW DL-001 (WKN: 249817)

MANHATTAN PHAR.NEW DL-001 (WKN: 249817), Manhattan Pharmaceuticals, Inc., (Amex: MHA - News) is a clinical-stage pharmaceutical company that acquires and develops novel, high-value drug candidates primarily in the areas of dermatologic/immunologic and endocrine/metabolic disease disorders. With a pipeline consisting of four clinical-stage product candidates, Manhattan Pharmaceuticals is developing potential therapeutics for large, underserved patient populations seeking superior treatments for conditions including psoriasis, atopic dermatitis (eczema), mastocytosis, and head lice. http://www.manhattanpharma. [mehr]